Nasdaq · CIK 0002079272
LABT Lakewood-Amedex Biotherapeutics Inc.
Insider trading from SEC Form 4. Last filing May 6, 2026.
In brief
Lakewood-Amedex Biotherapeutics Inc. (LABT) has 1 SEC Form 4 filing on file from 1 insider, the latest filed on May 6, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at Lakewood-Amedex Biotherapeutics Inc., scored.
Transactions
Every row filed, 1 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 24, 2026 | Joseph Edward Tucker director | AGrant or award Warrant to acquire Common Stockderivative | +33,784 | $0.00 | $0 | 33,784 | May 6, 2026 |
Questions about LABT
Answered from the filings on this page, as of the latest one.
Are insiders buying LABT?
No. In the last 90 days no insider at Lakewood-Amedex Biotherapeutics Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade LABT on the open market?
No open-market trade has been scored at Lakewood-Amedex Biotherapeutics Inc.. The latest Form 4 on file was filed on May 6, 2026 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at Lakewood-Amedex Biotherapeutics Inc.?
1 person has filed a Form 4 at Lakewood-Amedex Biotherapeutics Inc., among them Joseph Edward Tucker (CEO and director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.